| 水林佳为主治疗45例脂肪肝的临床分析 |
| |
| 引用本文： | 华忠,陈凯红. 水林佳为主治疗45例脂肪肝的临床分析[J]. 中国医院用药评价与分析, 2006, 6(3): 172-173 |
| |
| 作者姓名： | 华忠 陈凯红 |
| |
| 作者单位： | 江苏省无锡市传染病医院,无锡市,214000 |
| |
| 摘 要： | 目的:观察水林佳为主治疗脂肪肝的临床疗效。方法:水林佳和肌苷片为治疗组;益肝灵片和甘利欣胶囊为对照组。治疗12周。结果及结论:治疗组总有效率为77.7%,对照组总有效率为51.1%,差异有显著性,P<0.05。水林佳片为主治疗脂肪肝,使用方便,疗效明确,且不良反应少,值得临床推广使用。
|
| 关 键 词： | 水林佳 脂肪肝 临床疗效 |
| 文章编号： | 1672-2124(2006)03-0172-02 |
| 修稿时间： | 2006-04-25 |
Treating Adiposis Hepatica Chiefly with Silybinin: Clinical Analysis of 45 Cases |
| |
| HUA Zhong,CHEN Kaihong. Treating Adiposis Hepatica Chiefly with Silybinin: Clinical Analysis of 45 Cases[J]. Evaluation and Analysis of Drug-Use in Hospital of China, 2006, 6(3): 172-173 |
| |
| Authors: | HUA Zhong CHEN Kaihong |
| |
| Abstract: | OBJECTIVE: To observe the clinical efficacy of treating adiposis hepatica chiefly with silybinin. METHODS: The treatment group received silybinin plus riboside tablet and the control group received silymarin tablet and diammonium glycyrrhizinate capsule. Course of treatment was 12 weeks. RESULTS & CONCLUSION: The total effective rate of the treatment group was 77.7% and that of the control group was 51.1%, significances were noted between the two groups P<0.05. Treating adiposis hepatica chiefly with silybinin is convenient in administration, satisfactory in curative efficacy and less in adverse reactions; therefore, it deserves to be widely used in the clinic. |
| |
| Keywords: | silybinin adiposis hepatica clinical efficacy |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
